| |
|
       |
|
|
Gregory M. McKee
President & Chief Executive Officer
Gregory M. McKee was appointed President and Chief Executive Officer in April, 2005. Mr. McKee joined the Company in June 2003 serving as Vice President, Corporate Development & Strategic Planning and in December 2003, was named Chief Financial Officer. Mr. McKee brings over seventeen years of biotechnology industry, finance and management experience to the Company.
Previously Mr. McKee served as Senior Director, Corporate Development
for Valentis, Inc., a San Francisco based gene delivery company
where he was responsible for business development, marketing, and
investor relations. In his capacity at Valentis, Mr. McKee concluded
several transactions that have the potential to generate nearly
US$150 million. Mr. McKee's experience also includes several management
positions at Genzyme Corporation including Director - Asia where
he had responsibility for Genzyme's Singapore based operations
launching Cerezyme® and Seprafilm® into several countries in the
region. In addition, Mr. McKee held positions in business development
and marketing within the International and Diagnostics divisions
at Genzyme's Cambridge, Massachusetts headquarters.
Prior entering
the biotechnology industry Mr. McKee lived and worked in Tokyo,
Japan for seven years working as an investment banker and aide
to the former Minister of Foreign Affairs of Japan. Mr. McKee
earned a Bachelor's of Arts degree in Economics from the University
of
Washington, and holds a Master's of Arts degree in International
Studies from the Joseph H. Lauder Institute of the University
of Pennsylvania, and an MBA from The Wharton School.
|
|
